XML 42 R30.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT REPORTING (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
SCHEDULE OF BREAKDOWN OF SIGNIFICANT OPERATING EXPENSES | SCHEDULE OF BREAKDOWN OF SIGNIFICANT OPERATING EXPENSES
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
|  | Three months ended September 30, |  |  | Nine months ended September 30, |
|  | 2025 |  |  | 2024 |  |  | 2025 |  |  | 2024 |
Revenue |  | $ | - |  |  | $ | 487 |  |  | $ | - |  |  | $ | 581 |
Cost of revenues |  |  | - |  |  |  | (60 | ) |  |  | - |  |  |  | 96 |
Gross profit |  |  | - |  |  |  | 547 |  |  |  | - |  |  |  | 485 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development by significant expense: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
MSA/license fees |  |  | 510 |  |  |  | 767 |  |  |  | 1,810 |  |  |  | 2,392 |
Study fees |  |  | 60 |  |  |  | 48 |  |  |  | 472 |  |  |  | 200 |
Professional fees |  |  | 233 |  |  |  | 64 |  |  |  | 591 |  |  |  | 152 |
Payroll and related |  |  | 123 |  |  |  | 71 |  |  |  | 365 |  |  |  | 518 |
Other1 |  |  | 109 |  |  |  | 51 |  |  |  | 242 |  |  |  | 184 |
Research and development |  |  | 1,035 |  |  |  | 1,001 |  |  |  | 3,480 |  |  |  | 3,446 |
General and administrative by significant expense: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 284 |  |  |  | 392 |  |  |  | 1,123 |  |  |  | 1,036 |
Payroll and related |  |  | 313 |  |  |  | 367 |  |  |  | 1,134 |  |  |  | 1,234 |
Professional fees |  |  | 215 |  |  |  | 1,125 |  |  |  | 1,041 |  |  |  | 3,409 |
Occupancy expense |  |  | 6 |  |  |  | 1,267 |  |  |  | 21 |  |  |  | 5,068 |
Other2 |  |  | 140 |  |  |  | 230 |  |  |  | 426 |  |  |  | 845 |
General and administrative |  |  | 958 |  |  |  | 3,381 |  |  |  | 3,745 |  |  |  | 11,592 |
Gain on lease termination |  |  | - |  |  |  | (1,576 | ) |  |  | - |  |  |  | (1,576 | )
Total operating expenses |  |  | 1,993 |  |  |  | 2,806 |  |  |  | 7,225 |  |  |  | 13,462 |
Loss from operations |  |  | (1,993 | ) |  |  | (2,259 | ) |  |  | (7,225 | ) |  |  | (12,977 | )
Other income (expense), net |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Forward sales contract expense |  |  | - |  |  |  | - |  |  |  | (5,847 | ) |  |  | - |
Gain (loss) on extinguishment of debt |  |  | 734 |  |  |  | (22,440 | ) |  |  | 734 |  |  |  | (22,440 | )
Fair value adjustments to bridge notes derivative liability |  |  | - |  |  |  | (1,038 | ) |  |  | - |  |  |  | (1,038 | )
Change in fair value of warrant liabilities |  |  | - |  |  |  | 831 |  |  |  | 1 |  |  |  | 897 |
Change in fair value of contingent consideration |  |  | - |  |  |  | - |  |  |  | - |  |  |  | 66 |
Interest income (expense), net |  |  | 31 |  |  |  | (1,686 | ) |  |  | 36 |  |  |  | (3,269 | )
Other expense, net |  |  | (6 | ) |  |  | - |  |  |  | (264 | ) |  |  | - |
Total other income (expense), net |  |  | 759 |  |  |  | (24,333 | ) |  |  | (5,340 | ) |  |  | (25,784 | )
Loss before income taxes |  |  | (1,234 | ) |  |  | (26,592 | ) |  |  | (12,565 | ) |  |  | (38,761 | )
Provision for income taxes |  |  | (6 | ) |  |  | (12 | ) |  |  | (17 | ) |  |  | (19 | )
Net loss |  | $ | (1,240 | ) |  | $ | (26,604 | ) |  | $ | (12,582 | ) |  | $ | (38,780 | )
|  | September 30, 2025 |  |  | December 31, 2024 |
Cash |  | $ | 3,047 |  |  | $ | 1,729 |
1 | Other includes certain lab supply expenses, amounts related to the close out of a former clinical trial, allocated occupancy costs, stock-based compensation, and depreciation.
2 | Other includes expenses related to insurance, information technology, travel, banking, depreciation and other miscellaneous expenses.

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration